The Total Return for Sinocare (SZSE:300298) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
The Total Return for Sinocare (SZSE:300298) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But when you pick a company that is really flourishing, you can make more than 100%. Long term Sinocare Inc. (SZSE:300298) shareholders would be well aware of this, since the stock is up 144% in five years. It's also good to see the share price up 18% over the last quarter. This could be related to the recent financial results, released recently - you can catch up on the most recent data by reading our company report.
在買入公司股票(假設沒有槓桿作用)之後,最糟糕的結果是你損失了所有投入的錢。但是,當你選擇一家真正蓬勃發展的公司時,你可以 使 超過 100%。Sinocare Inc.(深交所代碼:300298)的長期股東會很清楚這一點,因爲該股在五年內上漲了144%。很高興看到股價在上個季度上漲了18%。這可能與最近公佈的最新財務業績有關——您可以通過閱讀我們的公司報告了解最新數據。
Although Sinocare has shed CN¥879m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.
儘管Sinocare本週市值已下跌8.79億元人民幣,但讓我們來看看其長期基本面趨勢,看看它們是否推動了回報。
See our latest analysis for Sinocare
查看我們對Sinocare的最新分析
To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
引用巴菲特的話說:“船隻將在世界各地航行,但Flat Earth Society將蓬勃發展。市場上的價格和價值之間將繼續存在巨大差異...”研究市場情緒如何隨着時間的推移而變化的一種方法是研究公司股價與其每股收益(EPS)之間的相互作用。
During five years of share price growth, Sinocare achieved compound earnings per share (EPS) growth of 3.4% per year. This EPS growth is slower than the share price growth of 20% per year, over the same period. So it's fair to assume the market has a higher opinion of the business than it did five years ago. That's not necessarily surprising considering the five-year track record of earnings growth.
在五年的股價增長中,Sinocare實現了每年3.4%的每股複合收益(EPS)增長。每股收益的增長低於同期股價每年20%的增長。因此,可以公平地假設市場對該業務的看法比五年前更高。考慮到五年的收益增長記錄,這並不一定令人驚訝。
You can see below how EPS has changed over time (discover the exact values by clicking on the image).
你可以在下面看到 EPS 是如何隨着時間的推移而變化的(點擊圖片發現確切的值)。
![earnings-per-share-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231107/0-1c111579cb9f34782bda8c25dcf3b4f7-0-e2d3ff3de2b5dff62f95e02563f19498.png/big)
It's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. Dive deeper into the earnings by checking this interactive graph of Sinocare's earnings, revenue and cash flow.
可能值得注意的是,首席執行官的薪水低於類似規模公司的中位數。但是,儘管首席執行官的薪酬總是值得檢查的,但真正重要的問題是公司未來能否增加收益。查看這張Sinocare收益、收入和現金流的交互式圖表,深入了解收益。
What About Dividends?
分紅呢?
When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Sinocare, it has a TSR of 160% for the last 5 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return.
在考慮投資回報時,重要的是要考慮兩者之間的區別 股東總回報 (TSR) 和 股價回報。股價回報僅反映股價的變化,而股東總回報率包括股息的價值(假設股息已被再投資)以及任何折扣融資或分拆的收益。可以說,股東總回報率可以更全面地描述股票產生的回報。就Sinocare而言,其過去5年的股東總回報率爲160%。這超過了我們之前提到的股價回報率。因此,該公司支付的股息促進了 總 股東回報。
A Different Perspective
不同的視角
While the broader market lost about 4.4% in the twelve months, Sinocare shareholders did even worse, losing 23% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. On the bright side, long term shareholders have made money, with a gain of 21% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Sinocare better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Sinocare , and understanding them should be part of your investment process.
儘管大盤在過去十二個月中下跌了約4.4%,但Sinocare股東的表現更糟,損失了23%(甚至包括股息)。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。好的一面是,長期股東已經賺了錢,在過去的五年中,每年收益爲21%。最近的拋售可能是一個機會,因此可能值得查看基本面數據以尋找長期增長趨勢的跡象。從長遠來看,追蹤股價表現總是很有意思的。但是,爲了更好地了解Sinocare,我們需要考慮許多其他因素。例如,以永遠存在的投資風險幽靈爲例。我們已經發現了Sinocare的1個警告信號,理解這些信號應該成爲您投資過程的一部分。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
當然,通過尋找其他地方,你可能會找到一筆不錯的投資。因此,請看一下我們預計收益將增加的這份免費公司名單。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。